New discovery offers progress in development of SARS treatment
This study, led by senior author Dr Paul Bates, an associate professor in the Department of Microbiology, also demonstrated a new mechanism for how viral proteins are activated
US-based biotechnology company Superluminal Medicines has completed a $60m Series B financing round to support its research into therapies for rare genetic forms of obesity and hypothalamic obesity.